Maplight Therapeutics, Inc. · NASDAQ:MPLT

Foff Erin Pennock sold 47,158 Maplight Therapeutics, Inc. shares (Form 4)

Traded Jul 15 to Jul 17, 2026 · Filed Jul 17, 2026

From Jul 15 to Jul 17, 2026, Foff Erin Pennock (Chief Medical Officer) sold 47,158 Maplight Therapeutics, Inc. shares at an average US$36.78 for US$1.73M under a trading plan, leaving 298,901 shares. Filed Jul 17, 2026 (Form 4).

Sold
47,158 shares
Price
US$36.78 average (US$36.00 to US$37.96)
Value
US$1.73M
Holding after
298,901 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Voting Common StockSale7,155US$36.16338,904Direct
Jul 15, 2026Voting Common StockSale7,845US$37.04331,059Direct
Jul 15, 2026Voting Common StockSale4,465US$36.00326,594Direct
Jul 15, 2026Voting Common StockSale8,972US$36.99317,622Direct
Jul 15, 2026Voting Common StockSale18US$37.54317,604Direct
Jul 16, 2026Voting Common StockSale9,163US$36.46308,441Direct
Jul 16, 2026Voting Common StockSale5,865US$37.26302,576Direct
Jul 16, 2026Voting Common StockSale19US$37.96302,557Direct
Jul 17, 2026Voting Common StockSale3,656US$37.90298,901Direct

Source

View original at SEC

Related